Skip to Content

691 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint 691 is White, Capsule-shape and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by Global Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 691

Divalproex sodium extended-release 250 mg 691

Divalproex Sodium Extended-Release

Imprint
691
Strength
250 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Global Pharmaceuticals
National Drug Code (NDC)
00115-6911
Inactive Ingredients
silicon dioxide, copovidone, calcium phosphate dihydrate dibasic, hydrogenated cottonseed oil, hypromelloses, polyethylene glycol, magnesium silicate, titanium dioxide, microcrystalline cellulose, stearic acid, xanthan gum

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "691"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.